Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 8, 2011, Pages 1745-1750

  Hocquet, Didier ^a   Colomb, Mélanie ^b   Dehecq, Barbara ^a   Belmonte, Olivier ^c   Courvalin, Patrice ^b   Plésiat, Patrick ^a   Meziane Cherif, Djalal ^b  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b INSTITUT PASTEUR   (France)

^c Centre hospitalier regional de La Reunion   (France)

Author keywords

Antibiotics; Ceftazidime; Point mutations; Resistance

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAMASE OXA 145; BETA LACTAMASE OXA 35; BICARBONATE; CEFALORIDINE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; DNA; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEUCINE; MONOBACTAM DERIVATIVE; NITROCEFIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; POLYHISTIDINE TAG; TICARCILLIN; UNCLASSIFIED DRUG;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BIOCHEMISTRY; CONTROLLED STUDY; DNA SEQUENCE; HYDROLYSIS; INTEGRON; ISOELECTRIC FOCUSING; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN PURIFICATION; PSEUDOMONAS AERUGINOSA; SITE DIRECTED MUTAGENESIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFTAZIDIME; CLONING, MOLECULAR; DNA, BACTERIAL; ESCHERICHIA COLI; HUMANS; HYDROLYSIS; ISOELECTRIC POINT; KINETICS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; PENICILLINS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 79960440151     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr187     Document Type: Article

References (29)

1. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34: 634-40.
2. Danel F, Page MGP, Livermore DM. Class D b-lactamases. In: Bonomo RA, Tolmasky ME, eds. Enzyme-Mediated Resistance to Antibiotics. Washington, DC: ASM Press, 2007; 163-94.
3. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 2010; 54: 24-38.
4. Mugnier P, Casin I, Bouthors AT et al. Novel OXA-10-derived extendedspectrum b-lactamases selected in vivo or in vitro. Antimicrob Agents Chemother 1998; 42: 3113-6.
5. Danel F, Hall LM, Gur D et al. OXA-15, an extended-spectrum variant of OXA-2 b-lactamase, isolated from a Pseudomonas aeruginosa strain. Antimicrob Agents Chemother 1997; 41: 785-90.
6. Juan C, Mulet X, Zamorano L et al. Detection of the novel extended-spectrum b-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain. Antimicrob Agents Chemother 2009; 53: 5288-90.
7. Hocquet D, Dehecq B, Bertrand X et al. A strain-tailored double-disc synergy test detects extended-spectrum oxacillinases in Pseudomonas aeruginosa. J Clin Microbiol 2011; doi:10.1128/JCM.02585-10.
8. Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother 2003; 47: 2385-92.
9. Rossolini GM, Docquier JD. Class B β-lactamases. In: Bonomo RA, Tolmasky ME, eds. Enzyme-Mediated Resistance to Antibiotics. Washington, DC: ASM Press, 2007; 115-44.
10. Couture F, Lachapelle J, Levesque RC. Phylogeny of LCR-1 and OXA-5 with class A and class D β-lactamases. Mol Microbiol 1992; 6: 1693-705.
11. Aubert D, Poirel L, Ali AB et al. OXA-35 is an OXA-10-related β-lactamase from Pseudomonas aeruginosa. J Antimicrob Chemother 2001; 48: 717-21.
12. Philippon L, Naas T, Bouthors A et al. OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1997; 41: 2188-95.
13. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.
14. Levesque C, Piche L, Larose C et al. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995; 39: 185-91.
15. Meziane-Cherif D, Lambert T, Dupechez M et al. Genetic and biochemical characterization of OXA-63, a new class D b-lactamase from Brachyspira pilosicoli BM4442. Antimicrob Agents Chemother 2008; 52: 1264-8.
16. Tolmasky ME, Crosa JH. Genetic organization of antibiotic resistance genes (aac(6')-Ib, aadA, and oxa9) in the multiresistance transposon Tn1331. Plasmid 1993; 29: 31-40.
17. Giske CG, Libisch B, Colinon C et al. Establishing clonal relationships between VIM-1-like metallo-β-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J Clin Microbiol 2006; 44: 4309-15.
18. Mugnier P, Podglajen I, Goldstein FW et al. Carbapenems as inhibitors of OXA-13, a novel, integron-encoded β-lactamase in Pseudomonas aeruginosa. Microbiology 1998; 144: 1021-31.
19. Levesque C, Brassard S, Lapointe J et al. Diversity and relative strength of tandem promoters for the antibiotic-resistance genes of several integrons. Gene 1994; 142: 49-54.
20. Fournier D, Hocquet D, Dehecq B et al. Detection of a new extended-spectrum oxacillinase in Pseudomonas aeruginosa. J Antimicrob Chemother 2010; 65: 364-5.
21. Pernot L, Frenois F, Rybkine T et al. Crystal structures of the class D b-lactamase OXA-13 in the native form and in complex with meropenem. J Mol Biol 2001; 310: 859-74.
22. Danel F, Hall LM, Duke B et al. OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999; 43: 1362-6.
23. Baurin S, Vercheval L, Bouillenne F et al. Critical role of tryptophan 154 for the activity and stability of class D b-lactamases. Biochemistry 2009; 48: 11252-63.
24. Paetzel M, Danel F, de Castro L et al. Crystal structure of the class D β-lactamase OXA-10. Nat Struct Biol 2000; 7: 918-25.
25. Danel F, Hall LM, Gur D et al. OXA-16, a further extended-spectrum variant of OXA-10 β-lactamase, from two Pseudomonas aeruginosa isolates. Antimicrob Agents Chemother 1998; 42: 3117-22.
26. Golemi D, Maveyraud L, Vakulenko S et al. Critical involvement of a carbamylated lysine in catalytic function of class D β-lactamases. Proc Natl Acad Sci USA 2001; 98: 14280-5.
27. Hall LM, Livermore DM, Gur D et al. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1993; 37: 1637-44.
28. Danel F, Hall LM, Gur D et al. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995; 39: 1881-4.
29. Danel F, Hall LM, Livermore DM. Laboratory mutants of OXA-10 β-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa. J Antimicrob Chemother 1999; 43: 339-44.